Showing results (211-220 of 277) with videos related to
Sort By:
Pageof 28
BMC Cancer|November 7, 2015
Outcome of vulvar reconstruction in patients with advanced and recurrent vulvar malignanciesWei Zhang, Ang Zeng, Jiaxin Yang, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 23, 2013
The occurrence of endometriosis with ovarian carcinomas is not purely coincidentalLin Qiu, Shu Wang, Jing He Lang, et al.Frontiers in Oncology|December 18, 2018
Piver Type II vs. Type III Hysterectomy in the Treatment of Early-Stage Cervical Cancer: Midterm Follow-up Results of a Randomized Controlled TrialHengzi Sun, Dongyan Cao, Keng Shen, et al.Oncotarget|February 11, 2016
The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute studyHuimin Bai, Guisha Sha, Meizhu Xiao, et al.World Journal of Surgical Oncology|August 16, 2017
Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive ageXuan Jiang, Jiaxin Yang, Mei Yu, et al.Frontiers in Oncology|September 27, 2021
Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing TherapyJunyu Chen, Dongyan Cao, Jiaxin Yang, et al.Gynecologic Oncology|August 2, 2012
A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumorsTing Gui, Dongyan Cao, Keng Shen, et al.Zhonghua Fu Chan Ke Za Zhi|May 8, 2004
[Clinical analysis of endometrial carcinoma patients aged 45 years and younger]Jin-song Gao, Keng Shen, Jing-he Lang, et al.Zhonghua Fu Chan Ke Za Zhi|January 13, 2009
[Comparison of effectiveness between intra-arterial and intra-venous neoadjuvant chemotherapy in stage Ib2-IIb cervical carcinoma]Dong-yan Cao, Jia-xin Yang, Keng Shen, et al.Chinese Medical Journal|July 12, 2011
Primary sarcoma of the ovary: clinicopathological characteristics, prognostic factors and evaluation of therapyYi Dai, Keng Shen, Jing-he Lang, et al.Pageof 28